Literature DB >> 2097702

Impact of the antibiotic dosage schedule on efficacy in experimental soft tissue infections.

A U Gerber1.   

Abstract

Soft tissue infection models have been used to study both the postantibiotic effect (PAE) and the effect of dosage intervals on antimicrobial efficacy. In vitro findings were mostly confirmed. For drug-organism combinations which showed a predominantly time-dependent killing pattern and absence of a PAE (beta-lactams vs Gram-negative organisms), frequent drug dosing was most efficacious. In contrast, a fast, predominantly concentration-dependent bactericidal effect followed by a PAE in vitro (e.g. aminoglycosides vs Gram-negative bacteria) correlated (though inconsistently) with superiority of bolus dosing over more continuous drug administration in vivo. Thus, the ratio of peak serum concentrations to MICs of target pathogens is possibly a valid predictor of efficacy for the aminoglycosides but not so for the activity of beta-lactam antibiotics where the duration of coverage at supra-MIC levels was clearly more important than the magnitude by which initial peaks exceeded the MIC of the target organism. It is not clear to what extent the results obtained in experimental soft tissue infections may hold true in man. Thus far, only a limited number of drug-organism combinations have been studied in well defined experimental settings using mostly small, granulocytopenic animals which differ pharmacokinetically from man. In addition, results are probably affected by the density of bacteria, their growth rate and metabolic activity, but also by the extent of inflammation at the site of infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2097702

Source DB:  PubMed          Journal:  Scand J Infect Dis Suppl        ISSN: 0300-8878


  7 in total

1.  Ceftibuten concentrations in human tonsillar tissue.

Authors:  F Scaglione; J P Pintucci; G Demartini; S Dugnani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-12       Impact factor: 3.267

2.  Penicillin pharmacodynamics in four experimental pneumococcal infection models.

Authors:  H Erlendsdottir; J D Knudsen; I Odenholt; O Cars; F Espersen; N Frimodt-Møller; K Fuursted; K G Kristinsson; S Gudmundsson
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model.

Authors:  U Flückiger; C Segessenmann; A U Gerber
Journal:  Antimicrob Agents Chemother       Date:  1991-09       Impact factor: 5.191

Review 4.  Pharmacokinetic contributions to postantibiotic effects. Focus on aminoglycosides.

Authors:  G G Zhanel; W A Craig
Journal:  Clin Pharmacokinet       Date:  1994-11       Impact factor: 6.447

5.  Simulation of human serum pharmacokinetics of cefazolin, piperacillin, and BRL 42715 in rats and efficacy against experimental intraperitoneal infections.

Authors:  G Woodnutt; V Berry; L Mizen
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

6.  Optimal times above MICs of ceftibuten and cefaclor in experimental intra-abdominal infections.

Authors:  C O Onyeji; D P Nicolau; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

7.  Quantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging.

Authors:  R Weissleder; K Poss; R Wilkinson; C Zhou; A Bogdanov
Journal:  Antimicrob Agents Chemother       Date:  1995-04       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.